BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16998571)

  • 1. Back to the future: postoperative pain management beyond COX-2 inhibitors.
    Naesh O
    N Z Med J; 2006 Sep; 119(1242):U2170. PubMed ID: 16998571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the role of nonsteroidal anti-inflammatory drugs and coxibs in the management of acute pain.
    Reuben SS
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):440-50. PubMed ID: 17873597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxibs: is there a benefit when compared to traditional non-selective NSAIDs in postoperative pain management?
    Wickerts L; Warrén Stomberg M; Brattwall M; Jakobsson J
    Minerva Anestesiol; 2011 Nov; 77(11):1084-98. PubMed ID: 21617597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [COX-2 Inhibitors for the management of postoperative pain].
    Schug SA
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Jan; 45(1):56-63. PubMed ID: 20091477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
    Hermann M; Ruschitzka F
    Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal anti-inflammatory drugs: are they safe after joint arthroplasty for early pain?
    Purtill JJ
    Instr Course Lect; 2007; 56():133-7. PubMed ID: 17472301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do steroids, conventional non-steroidal anti-inflammatory drugs and selective Cox-2 inhibitors adversely affect fracture healing?
    Boursinos LA; Karachalios T; Poultsides L; Malizos KN
    J Musculoskelet Neuronal Interact; 2009; 9(1):44-52. PubMed ID: 19240368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
    Vardeny O; Solomon SD
    Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
    Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.
    Joshi GP; Gertler R; Fricker R
    Anesth Analg; 2007 Dec; 105(6):1793-804, table of contents. PubMed ID: 18042885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?
    Lazzaroni M; Battocchia A; Bianchi Porro G
    Dig Liver Dis; 2007 Jun; 39(6):589-96. PubMed ID: 17459794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs].
    Lange H; Eberhart L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jul; 42(7):514-7. PubMed ID: 17661262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of chronic musculoskeletal pain in the elderly: opinions on oral medication use.
    Kean WF; Rainsford KD; Kean IR
    Inflammopharmacology; 2008 Apr; 16(2):53-75. PubMed ID: 18389178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.
    Vuolteenaho K; Moilanen T; Moilanen E
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):10-4. PubMed ID: 17973900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of musculoskeletal conditions.
    Austin MS; Abdul-Hadi O; Parvizi J; Viscusi ER; Einhorn T
    Instr Course Lect; 2009; 58():759-68. PubMed ID: 19385584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
    Moore RA; Derry S; Phillips CJ; McQuay HJ
    BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
    Dajani EZ; Islam K
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern aspects of perioperative analgesia by using nonsteroidal anti-inflammatory drugs in gynecology (Part I)].
    Tablov B; Tablov V; Popov I
    Akush Ginekol (Sofiia); 2006; 45(1):41-4. PubMed ID: 16637318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern aspects of perioperative analgesia by using nonsteroidal anti-inflammatory drugs in gynecology (Part II)].
    Tablov B; Tablov V; Popov I
    Akush Ginekol (Sofiia); 2006; 45(2):44-8. PubMed ID: 16637304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.